RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 7:55 PM
Followers: 439
Posts Today: 23
Views Today: 44800

CYDY Stock Quote & Tools

$0.2054 ▲ +0.0054 (+2.69%) As of Oct 15, 3:59 PM EDT
Last0.2054
$ Chg0.0054
Open0.2000
High0.2090
Beta1.4964
Year High0.397
Market Cap301.80M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume3.28M
% Chg+2.69%
Prev Close0.2000
Low0.1971
VWAP0.20198
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. StinkyPennies

    After reading this, do your own research to confirm and I think you'll become really excited and

    (1)
  2. CDiddy

    I believe you are correct. Makes me wonder if electing 1 or 2 of these folks would be a good

    (5)
  3. CDiddy

    I believe tropism was an inclusion criteria.

    (1)
  4. Riztheinvestor

    Elaborate pls the only person I like on there is Bruce....

    (1)
  5. Riztheinvestor

    I wouldnt mind Bruce as CMO .

  6. Flash08

    5%er.Strongly doubt these 5 have a chance. Spoke with many stockholders and all believe this is

    (2)
  7. Good to go

    I remember voting for each person individually last year. Wont it be the same this year? Are we

    (3)
  8. PTM1

    Dream team?

  9. Flash08

    Agree 200%

  10. swordman

    This will get deleted by rabbit et al--but until we all see the RTF--until anyone that can do what

    (2)
  11. sean007

    The only tangible thing that the (SLC) aka 13D think tank has done... is to create a rift between

    (6)
  12. 5%er

    Where do you get Xmas 2023? Please provide such details as to where that is noted, or let us know

  13. CaptnAmerca

    Once again, WHAT ARE YOU GOING TO DO DIFFERENTLY? Nice list of names and complaints. WHAT ARE

    (12)
  14. Remote

    Is the company making progress during the time? I think the answer is yes. Stock price only

    (4)
  15. StinkyPennies

    I'd urge you to re-read the end of their letter - the potential board nominees are rockstars. If

    (4)
  16. stevo180

    If we could just add one director wouldnt BP be great. It would force him and NP to come to terms

    (4)
  17. jacketsndisney

    Could a moderator post the board's rules for discussing the upcoming election? I had two posts

    (3)
  18. Shelly2626

    They will nominate 5 directors that then will go ahead and put their own buddies in as management

    (7)
  19. Remote

    Why would shareholders vote for the new nominees ? what did they accomplished?

    (3)
  20. RTB

    "Game on" is right. What a fun day.....13d unveils their slate and begins their "pitch." CYDY

    (4)
  21. LaundryMoney

    Recknor just hit his milestone on time when the company said he would. That's enough to almost

    (9)
  22. FBCoach18

    With the same disclaimer about forward-looking statement, lol! How about a little Pat Benatar "Hit

    (5)
  23. HCIT

    Yes Mels, WOW, what a print of the PR. It's the best one I've seen in over 5 years, it's concise

    (7)
  24. melsdollars

    New PR:

    (8)
  25. Riztheinvestor

    CytoDyn Submits Dose Justification Report to FDA to Begin Overcoming Deficiencies in its BLA for

    (6)
  26. Shelly2626

    Recruiting a new management team Hah...guess we'll wait for Xmas 2023 for our presents

    (2)
  27. onestepahead

    All they do is tell us what coulda should woulda Monday morning QB. No Great Plan - no vote for

    (17)
  28. KenChowder

    I cant speak for any one else, but I have not nor will I bash Nader or anyone else.

    (12)
  29. Evil Rabbit

    Kudos to the group for finally coming out of the shadows. I was hoping for more than "We're

    (2)
  30. TonyCorvette

    $CYDY ICYMI

    (1)
  31. Evil Rabbit

    There's the names: A group of long-time stockholders (the Nominating Stockholders) of

    (1)
  32. Riztheinvestor

    News out

  33. HHIGambler

    DFAN14A: Definitive additional proxy soliciting materials filed by non-management including Rule

    (2)
  34. Evil Rabbit

    I have not nor will I bash Nader or anyone else. Then you have my apology and

    (1)
  35. Northstar42

    I cant speak for any one else, but I have not nor will I bash Nader or anyone else.

    (3)
  36. melsdollars

    Thanks Enjay. This is good news. I seem to recall some discussion regarding Patterson attempting

    (2)
  37. Evil Rabbit

    I really don't understand what is not fair. Everyone has a voice. I use mine carefully,

    (5)
  38. Evil Rabbit

    hypothetical--suppose "they" only want to replace 1 board member (Naydenov). Does that count

    (4)
  39. Northstar42

    I really don't understand what is not fair. Everyone has a voice. I use mine carefully, don't

    (6)
  40. JLang

    No, just a Mole

    (1)
  41. dawsonmackay

    Thank you.

  42. swordman

    hypothetical--suppose "they" only want to replace 1 board member (Naydenov). Does that count as a

  43. Enjay

    Here is a link to a 173-page PDF document of the patent which may be a little easier to read.

    (2)
  44. WUM

    From reddit: https://patents.justia.com/assignee/cytodyn-inc

    (1)
  45. Evil Rabbit

    There can be no "Mgmt takeover", a fairly conducted BOD election, yes! Semantics.

    (4)
  46. dawsonmackay

    A small bit of news: small - posted a couple of messages ago. Sorry

    (3)
  47. carpediemdriver

    Sorry if this has already been posted Date of Patent: June 29, 2021 but it seems to be inline with

    (5)
  48. Northstar42

    There can be no "Mgmt takeover", a fairly conducted BOD election, yes!

    (3)
  49. Evil Rabbit

    No news, low volume, and a planned attempt at a Mgmt takeover will do that to a pps every time.

    (3)
  50. Beasley

    And the pps keeps going lower

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

AST SpaceMobile: Analyzing Growth Amid Market Fluctuations

Updated Category News Views 151

Market Movement and AST SpaceMobile's Growth Potential AST SpaceMobile Inc (NASDAQ: ASTS) has recently experienced a period of consolidation following a remarkable rally that saw its stock increase by triple digits in under three months. For investors monitoring the daily fluctuations in AST SpaceMobile’s stock chart, this pullback may trigger concerns. However, the...

Continue Reading
Foghorn Therapeutics: Future Directions and Financial Health

Updated Category News Views 92

Foghorn Therapeutics: Future Directions and Financial Health Foghorn Therapeutics Inc. (NASDAQ: FHTX) is embarking on an exciting journey in the field of oncology, focusing on groundbreaking therapies that seamlessly integrate with the body’s chromatin regulatory mechanisms. Among these is FHD-909, a pioneering oral selective SMARCA2 inhibitor. This focus highlights the...

Continue Reading
Essen Health Achieves Top Savings Rate in 2024

Updated Category News Views 11

Leading the Pack with Impressive Savings When it comes to healthcare innovation and cost efficiency, Essen Health Care's Atlas IPA is firing on all cylinders. In the cutthroat world of healthcare savings, where every penny counts, they’ve managed to crank out a 21% net savings rate. This isn’t just a small-town record, folks. We're talking about leading the nation...

Continue Reading
Alps Group Completes Merger with Globalink Investment and Expands

Updated Category News Views 242

Alps Group's Landmark Merger with Globalink Investment Inc. Alps Group Inc, the parent company of Alps Life Sciences Inc., recently celebrated the closing of its business combination with Globalink Investment Inc. This merger marks a significant milestone in the biotechnology landscape, showcasing Alps Group's commitment to advancing healthcare solutions. The Journey to...

Continue Reading
Morien Resources Secures Funding for Future Development Goals

Updated Category News Views 75

Morien Resources Corp. Secures Financing Morien Resources Corp. is thrilled to announce the successful closing of a significant non-brokered Listed Issuer Financing Exemption offering, known as the LIFE Offering. The company has raised gross proceeds of $1,600,000, allowing it to issue 8,888,889 common shares at a price of $0.18 each. This injection of capital is pivotal...

Continue Reading